Management of ASMD - Expert opinion: Professor Tawfeq Ben Omran
Professor Tawfeq explains the benefits of the ERT Olipudase Alfa on patients diagnosed with ASMD.
Related articles
MAT-KW-2300271
Professor Tawfeq explains the benefits of the ERT Olipudase Alfa on patients diagnosed with ASMD.
By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.